JP2016516762A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016516762A5 JP2016516762A5 JP2016507059A JP2016507059A JP2016516762A5 JP 2016516762 A5 JP2016516762 A5 JP 2016516762A5 JP 2016507059 A JP2016507059 A JP 2016507059A JP 2016507059 A JP2016507059 A JP 2016507059A JP 2016516762 A5 JP2016516762 A5 JP 2016516762A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- pharmaceutically acceptable
- acceptable salt
- nalidixic acid
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201306413A GB201306413D0 (en) | 2013-04-09 | 2013-04-09 | The local treatment of ophthalmic diseases |
| GB201306411A GB201306411D0 (en) | 2013-04-09 | 2013-04-09 | Treatment of inflammatory conditions |
| GB1306411.8 | 2013-04-09 | ||
| GB1306413.4 | 2013-04-09 | ||
| PCT/GB2014/051109 WO2014167327A1 (en) | 2013-04-09 | 2014-04-09 | The treatment of inflammatory disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016516762A JP2016516762A (ja) | 2016-06-09 |
| JP2016516762A5 true JP2016516762A5 (cg-RX-API-DMAC7.html) | 2017-06-01 |
Family
ID=50489339
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016507058A Pending JP2016516761A (ja) | 2013-04-09 | 2014-04-09 | 炎症性眼疾患の局所治療 |
| JP2016507059A Pending JP2016516762A (ja) | 2013-04-09 | 2014-04-09 | 炎症性障害の治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016507058A Pending JP2016516761A (ja) | 2013-04-09 | 2014-04-09 | 炎症性眼疾患の局所治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20160051526A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2983788A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2016516761A (cg-RX-API-DMAC7.html) |
| CN (2) | CN105555364A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2014252807A1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2909117A1 (cg-RX-API-DMAC7.html) |
| GB (2) | GB2516137B (cg-RX-API-DMAC7.html) |
| HK (2) | HK1221166A1 (cg-RX-API-DMAC7.html) |
| RU (2) | RU2015145135A (cg-RX-API-DMAC7.html) |
| WO (2) | WO2014167326A1 (cg-RX-API-DMAC7.html) |
| ZA (2) | ZA201507724B (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104496986A (zh) * | 2014-12-12 | 2015-04-08 | 苏州亚科化学试剂股份有限公司 | 萘啶酸的制备方法 |
| WO2017073708A1 (ja) * | 2015-10-29 | 2017-05-04 | テイカ製薬株式会社 | 外用剤 |
| AU2017336765B2 (en) * | 2016-09-28 | 2023-06-08 | Medicon Pharmaceuticals, Inc. | Compositions and methods for treating ophthalmic conditions |
| WO2020021035A1 (en) * | 2018-07-26 | 2020-01-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of antibiotics for the treatment of immunoglobulin a nephropathy |
| CA3128947A1 (en) * | 2019-02-08 | 2020-08-13 | Frequency Therapeutics, Inc. | Quinolin-4-one and 4(1h)-cinnolinone compounds and methods of using same |
| MX2022002961A (es) * | 2019-09-11 | 2022-04-06 | Adverum Biotechnologies Inc | Metodos para tratar enfermedades neovasculares oculares usando variantes de aav2 que codifican para aflibercept. |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19633480A1 (de) * | 1996-08-20 | 1998-02-26 | Bayer Ag | Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren |
| ID23053A (id) * | 1997-06-04 | 2000-01-20 | Lilly Co Eli | Karboksamida yang digunakan sebagai agonis 5-ht <if> |
| DE19729879C2 (de) * | 1997-07-11 | 1999-07-08 | Mann Gerhard Chem Pharm Fab | Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin |
| DE19826050A1 (de) * | 1998-06-12 | 1999-12-16 | Bayer Ag | Verfahren zur Herstellung von Chinolon- und Naphthyridoncarbonsäuren und deren Ester |
| CN1090959C (zh) * | 1999-06-17 | 2002-09-18 | 卢世全 | 一种治疗咳喘病的中、西复方成药及制备方法 |
| US6552020B1 (en) * | 1999-07-30 | 2003-04-22 | Allergan, Inc. | Compositions including antibiotics and methods for using same |
| JP2001342188A (ja) * | 2000-03-27 | 2001-12-11 | Takeda Chem Ind Ltd | 縮合ピラゾール誘導体、その製造法および用途 |
| JP3648132B2 (ja) * | 2000-06-19 | 2005-05-18 | 大正薬品工業株式会社 | キノロン系抗菌薬液体製剤及びその包装体 |
| WO2003004098A1 (en) * | 2001-07-06 | 2003-01-16 | Sucampo Ag | Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| AUPS017702A0 (en) * | 2002-01-25 | 2002-02-14 | Atopic Pty Ltd | Methods and compositions for the treatment of asthma and related disorders |
| EP4218730B1 (en) * | 2004-05-03 | 2023-11-01 | Ipsen Biopharm Ltd. | Liposomes useful for drug delivery |
| ME02799B (me) * | 2004-06-24 | 2018-01-20 | Vertex Pharma | Modulatori ATP-vezujućih kasetnih transportera |
| JP2006028031A (ja) * | 2004-07-12 | 2006-02-02 | Ltt Bio-Pharma Co Ltd | 経粘膜吸収用薬物封入ナノ粒子 |
| KR101506925B1 (ko) * | 2004-10-01 | 2015-03-30 | 램스코르 인코포레이티드 | 편리하게 이식가능한 서방형 약물 조성물 |
| EP1954800A4 (en) * | 2005-12-02 | 2010-03-03 | Health Enhancement Products In | COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE |
| US20080138350A1 (en) * | 2006-10-20 | 2008-06-12 | Bennett Michael D | Process for use of fluoroquinolones to reduce or modulate inflammation due to eye disease or ophthalmic surgery |
| CN101129386A (zh) * | 2007-07-17 | 2008-02-27 | 长治市三宝生化药业有限公司 | 一种含环丙沙星和地塞米松的局部悬浮滴眼剂 |
| CN101801414B (zh) * | 2007-09-21 | 2013-04-03 | 株式会社日本高度医疗研究会 | 口腔用和皮肤用组合物 |
| GB0719518D0 (en) * | 2007-10-05 | 2007-11-14 | Therapeutics Ltd E | Therapy |
| NZ583970A (en) * | 2007-10-11 | 2011-04-29 | Univ California | Compositions and methods of inhibiting n-acylethanolamine-hydrolyzing acid amidase |
| MX2008014515A (es) * | 2008-09-09 | 2010-04-29 | Allergan Inc | Suspension oftalmica para uso ocular. |
| US8629139B2 (en) * | 2008-10-07 | 2014-01-14 | Mpex Pharmaceuticals, Inc. | Topical use of Levofloxacin for reducing lung inflammation |
| AU2010284678A1 (en) * | 2009-08-19 | 2012-02-23 | Mpex Pharmaceuticals, Inc. | Use of aerosolized antibiotics for treating chronic obstructive pulmonary disease |
| US20130079353A1 (en) * | 2009-12-22 | 2013-03-28 | Karsten Gülow | Fluoroquinolones for the treatment and/or prophylaxis of inflammatory diseases |
| ES2836808T3 (es) * | 2011-04-05 | 2021-06-28 | Optosolve Res & Development Ltd | Tratamientos oftálmicos |
-
2014
- 2014-04-09 WO PCT/GB2014/051108 patent/WO2014167326A1/en not_active Ceased
- 2014-04-09 RU RU2015145135A patent/RU2015145135A/ru not_active Application Discontinuation
- 2014-04-09 WO PCT/GB2014/051109 patent/WO2014167327A1/en not_active Ceased
- 2014-04-09 US US14/783,038 patent/US20160051526A1/en not_active Abandoned
- 2014-04-09 CN CN201480030418.5A patent/CN105555364A/zh active Pending
- 2014-04-09 JP JP2016507058A patent/JP2016516761A/ja active Pending
- 2014-04-09 HK HK16109377.6A patent/HK1221166A1/zh unknown
- 2014-04-09 CA CA2909117A patent/CA2909117A1/en not_active Abandoned
- 2014-04-09 EP EP14717820.6A patent/EP2983788A1/en not_active Withdrawn
- 2014-04-09 HK HK16109376.7A patent/HK1221190A1/zh unknown
- 2014-04-09 GB GB1406390.3A patent/GB2516137B/en active Active
- 2014-04-09 CA CA2909111A patent/CA2909111A1/en not_active Abandoned
- 2014-04-09 GB GB1406396.0A patent/GB2516138C/en active Active
- 2014-04-09 JP JP2016507059A patent/JP2016516762A/ja active Pending
- 2014-04-09 AU AU2014252807A patent/AU2014252807A1/en not_active Abandoned
- 2014-04-09 CN CN201480030407.7A patent/CN105431172A/zh active Pending
- 2014-04-09 AU AU2014252808A patent/AU2014252808A1/en not_active Abandoned
- 2014-04-09 RU RU2015145134A patent/RU2015145134A/ru not_active Application Discontinuation
- 2014-04-09 EP EP14717821.4A patent/EP2983713A1/en not_active Withdrawn
- 2014-04-09 US US14/782,975 patent/US20160068527A1/en not_active Abandoned
-
2015
- 2015-10-15 ZA ZA2015/07724A patent/ZA201507724B/en unknown
- 2015-10-15 ZA ZA201507718A patent/ZA201507718B/en unknown